8 > CONTAINS NUM EV (CDXX17, $99SUP159, “Administered activity”) 1 M Units = EV (MBq, UCUM, “MBq”) 9 > CONTAINS NUM EV (123005, DCM, Volume”) 1 U Units = EV (cm3, UCUM, “cm3”) 10 > CONTAINS NUM EV (123007, DCM, Specific Activity”) 1 U Units = EV (Bq/mol, UCUM, “Bq/mol”) 1 > CONTAINS CODE EV (C-B1000, SRT, “Diagnostic Radioisotope”) 1 M DCID 18 (NM) or 4020 (PET) 1 > CONTAINS NUM EV (CDXX25, $99SUP159, “Radionuclide Half Life”) 1 M Units = EV (s, UCUM, “seconds”) 1 > CONTAINS NUM EV (CDXX34, $99SUP159, Measured Activity”) 1 U Units = EV (MBq, UCUM, “MBq”) 1 >> HAS OBS CONTEXT CODE EV (CDXX36, $99SUP159, “Source of Activity Measurement”) 1 U DCID CXXX3 1 >> HAS OBS CONTEXT INCLUDE DTID (1002) Observer Context 1-n U 1 >> HAS OBS CONTEXT DATETME EV (CDXX35, $99SUP159, “Measured Activity Date Time”) 1 U
> CONTAINS NUM EV (CDXX143, $99SUP159, Measured Activity”) 1 U Units = EV (MBq, UCUM, “MBq”) >> HAS OBS CONTEXT CODE EV (CDXX36, $99SUP159, “Source of Activity Measurement”) 1 U DCID CXXX3 >> HAS OBS CONTEXT INCLUDE DTID (1002) Observer Context 1-n U 2 >> HAS OBS CONTEXT DATETME EV (CDXX35, $99SUP159, “Measured Activity Date Time”) 1 U 2 > CONTAINS INCLUDE DTID (XXXX7) Administration Patient Characteristics 1 M 2 > CONTAINS INCLUDE DTID (XXXX5) Administration Organ Data 1 U 2 > CONTAINS CODE EV (121147, DCM, “Billing Code”) 1-n U local billing codes 2 > CONTAINS INCLUDE DTID (XXX11) Product Administration Data 1 M 2 > CONTAINS TEXT EV (121106, DCM, “Comment”) 1 U Content Item Descriptions Row 3 Unique identification of a single radiopharmaceutical administration event. Row 5 The estimated percentage of administered activity lost at the injection site. The estimation includes extravasation, paravenous administration and leakage at the injection site. Row 6 The time the radiopharmaceutical was administered to the patient for imaging purposes.
6 > NUM EV (CDXX32, $99SUP159, “Estimated Mass of Organ”) 1 U Units= EV (g, UCUM, “grams”) 7 >> HAS MOD TEXT EV (G-C036, SRT, “Measurement Method”) 1 M Content Item Descriptions Row 3 Organ dose ( in units of mGy). Organ is specified by row 2. Row 6 The estimated mass of organ in grams used when calculating the organ dose. Row 7 Method used to obtain the estimate. This could include a method that does not involve performing a measurement. (E.g., Standard Organ Mass Tables) TID XXXX7 Radiopharmaceutical Administration Patient Characteristics This template describes the characteristics of the patient that are specific to the current clinical presentation (visit). The characteristics noted may affect the activity received, and how dose is calculated for the patient. Patient Characteristic concepts in this template, which may replicate attributes in the Patient Study Module, are included here as possible targets of by-reference relationships from other content items in the SR tree. TID XXXX7 Radiopharmaceutical ADMINISTRATION PATIENT CHARACTERISTICS Type: Extensible Order: Significant NL Rel with Parent VT Concept Name VM Req Type Condition Value Set Constraint 1 CODE EV (109054, DCM, ”Pathological states”) 1-n U DCID (CXX14) Radiopharmaceutical Patient States 2 NUM EV (121033, DCM, “Subject Age”) 1 M DCID (7456) Units of Measure for Age 3 CODE EV (121032, DCM, “Subject Sex”) 1 M DCID (7455) Sex 4 NUM EV (8302-2, LN, “Patient Height”) 1 U UNITS = EV (cm, UCUM, “cm”) 5 NUM EV (29463-7, LN, “Patient Weight”) 1 M UNITS = EV (kg, UCUM, “kg”). 6 NUM EV (8277-6, LN, “Body Surface Area”) 1 U UNITS = EV (m2, UCUM, “m^2”)